Sol-Gel Technologies (SLGL) Current Leases (2019 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Current Leases of $485000.0 for Q1 2026, up 12.01% year-over-year from $433000.0 in Q1 2025, and down 2.02% quarter-over-quarter from $495000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Current Leases (2019 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Current Leases for 8 consecutive years, with $485000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 12.01% year-over-year to $485000.0; the TTM figure through Mar 2026 stood at $485000.0 (up 12.01% YoY), while the FY2025 annual figure was $495000.0, up 15.12% from the prior year.
- Current Leases eased to $485000.0 in Q1 2026 per SLGL's latest filing, from $495000.0 in the prior quarter.
- Across five years, Current Leases topped out at $766000.0 in Q1 2022 and bottomed at $376000.0 in Q2 2024.
- Historically, Current Leases has averaged $513352.9 across 5 years, with a median of $482000.0 in 2025.
- Annual changes were most pronounced in 2023 — Current Leases slumped 38.23% — and 2025, when it rose 28.19%.
- Sol-Gel Technologies' Current Leases stood at $718000.0 in 2022, then sank by 37.74% to $447000.0 in 2023, then declined by 3.8% to $430000.0 in 2024, then increased by 15.12% to $495000.0 in 2025, then fell by 2.02% to $485000.0 in 2026.
- Business Quant data shows SLGL's Current Leases at $485000.0 in Q1 2026, $495000.0 in Q4 2025, and $491000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | 485,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 485,000.00 |
| Dec 31, 2025 | 495,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 384,000.00 |
| Jun 30, 2024 | 376,000.00 |
| Mar 31, 2024 | 386,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 467,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 701,000.00 |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 781,000.00 |
| Sep 30, 2021 | 652,000.00 |
| Jun 30, 2021 | 649,000.00 |